These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9049488

  • 61. Diabetic nephropathy in insulin-dependent diabetic patients: renal hemodynamics and derived treatment strategies.
    ter Wee PM, Donker JM.
    J Diabet Complications; 1989; 3(2):62-9. PubMed ID: 2526142
    [Abstract] [Full Text] [Related]

  • 62. Coronary artery disease in diabetic patients with nephropathy.
    Manske CL.
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):367S-374S. PubMed ID: 8297545
    [Abstract] [Full Text] [Related]

  • 63. Risk factors and risk determinants for the evolution of the diabetic nephropathy in IDDM: a case control study of 108 IDDM patients in the Bucharest Center of Diabetes.
    Ionescu-Tîrgovişte C, Serafinceanu C, Iosif MC, Mincu I.
    Rom J Intern Med; 1993 Nov; 31(4):245-56. PubMed ID: 8148776
    [Abstract] [Full Text] [Related]

  • 64. Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent diabetes mellitus and persistent proteinuria.
    Warram JH, Laffel LM, Ganda OP, Christlieb AR.
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S104-10. PubMed ID: 1457752
    [Abstract] [Full Text] [Related]

  • 65. Diabetic nephropathy. Metabolic versus hemodynamic considerations.
    Hostetter TH.
    Diabetes Care; 1992 Sep; 15(9):1205-15. PubMed ID: 1396017
    [Abstract] [Full Text] [Related]

  • 66. Lack of evidence of hypervolemia in children with insulin-dependent diabetes mellitus.
    Raes A, Van Aken S, Craen M, Donckerwolcke R, Vande Walle J.
    Pediatr Nephrol; 2007 Feb; 22(2):258-64. PubMed ID: 17115199
    [Abstract] [Full Text] [Related]

  • 67. The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathy.
    Makarious M, Pawlak M, Campbell LV, Timmermans V, Duggan K, Charlesworth JA, Macdonald GJ.
    Eur J Clin Invest; 1993 Sep; 23(9):517-21. PubMed ID: 8243521
    [Abstract] [Full Text] [Related]

  • 68. Low birth weight. A risk factor for development of diabetic nephropathy?
    Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH.
    Diabetes; 1995 Dec; 44(12):1405-7. PubMed ID: 7589846
    [Abstract] [Full Text] [Related]

  • 69. Immune complexes in insulin-dependent diabetes.
    Contreas G, Lernmark A, Mathiesen ER, Deckert T.
    Biomed Biochim Acta; 1985 Dec; 44(1):129-32. PubMed ID: 3994705
    [Abstract] [Full Text] [Related]

  • 70. Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy.
    Pedagogos E, Hewitson T, Fraser I, Nicholls K, Becker G.
    Am J Kidney Dis; 1997 Jun; 29(6):912-8. PubMed ID: 9186078
    [Abstract] [Full Text] [Related]

  • 71. Proteinuria and activated T-lymphocytes in diabetic nephropathy.
    Bending JJ, Lobo-Yeo A, Vergani D, Viberti GC.
    Diabetes; 1988 May; 37(5):507-11. PubMed ID: 3258834
    [Abstract] [Full Text] [Related]

  • 72. Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy.
    Soussan K, Dausse E, Hannedouche T, Timsit J, Lemoult F, Boitard C, Grünfeld JP, Guicheney P.
    Am J Hypertens; 1993 Feb; 6(2):170-3. PubMed ID: 8385959
    [Abstract] [Full Text] [Related]

  • 73. Albumin antioxidant response to stress in diabetic nephropathy progression.
    Medina-Navarro R, Corona-Candelas I, Barajas-González S, Díaz-Flores M, Durán-Reyes G.
    PLoS One; 2014 Feb; 9(9):e106490. PubMed ID: 25187963
    [Abstract] [Full Text] [Related]

  • 74. Renal papillary necrosis in patients with IDDM.
    Groop L, Laasonen L, Edgren J.
    Diabetes Care; 1989 Mar; 12(3):198-202. PubMed ID: 2702911
    [Abstract] [Full Text] [Related]

  • 75. Effect of kidney dysfunction on lung volume in patients with diabetes.
    Gilmour IJ, Barbosa JJ.
    Diabetes Care; 1991 Apr; 14(4):333-5. PubMed ID: 2060436
    [Abstract] [Full Text] [Related]

  • 76. Approach to early-stage nephropathy in childhood-onset insulin-dependent diabetes.
    Amemiya S, Ishihara T, Higashida K, Kato K.
    Acta Paediatr Jpn; 1988 Apr; 30 Suppl():28-34. PubMed ID: 3146873
    [No Abstract] [Full Text] [Related]

  • 77. Glucosaminyl N-deacetylase in cultured fibroblasts; comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition.
    Kofoed-Enevoldsen A, Petersen JS, Deckert T.
    Diabetologia; 1993 Jun; 36(6):536-40. PubMed ID: 8335176
    [Abstract] [Full Text] [Related]

  • 78. Lens fluorescence in relation to nephropathy in insulin-dependent diabetes mellitus.
    Larsen M, Kjer B, Bendtson I, Dalgaard P, Lund-Andersen H.
    Graefes Arch Clin Exp Ophthalmol; 1992 Jun; 230(1):6-10. PubMed ID: 1547969
    [Abstract] [Full Text] [Related]

  • 79. The nephrotic syndrome at presentation of insulin-dependent diabetes mellitus; cause or coincidence?
    Dornan TL, Jenkins S, Cotton RE, Tattersall RB, Burden RP.
    Diabet Med; 1988 Jun; 5(4):387-90. PubMed ID: 2968891
    [Abstract] [Full Text] [Related]

  • 80. [Diabetic nephropathy].
    Siciński A.
    Pol Arch Med Wewn; 1977 Jul; 58(1):77-87. PubMed ID: 887466
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.